✦ LIBER ✦

Primary Endpoint Results of the EVOLVE Trial: A Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

✍ Scribed by Ian T. Meredith; Stefan Verheye; Christophe L. Dubois; Joseph Dens; Jean Fajadet; Didier Carrié; Simon Walsh; Keith G. Oldroyd; Olivier Varenne; Seif El-Jack; Raul Moreno; Anita A. Joshi; Dominic J. Allocco; Keith D. Dawkins

Book ID: 119271712
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 480 KB
Volume: 59
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2011.12.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Prospective, Randomized Evaluation of

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent: The PLATINUM (A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of up to Two De Novo Coronary Artery Lesions) Trial

✍ Gregg W. Stone; Paul S. Teirstein; Ian T. Meredith; Bruno Farah; Christophe L. D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 825 KB

TCT-15 Results of the Primary Endpoint o

TCT-15 Results of the Primary Endpoint of the PLATINUM PLUS Trial: A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients

✍ Fajadet, Jean; Garcia, Eulogio J.; Hildick-Smith, David; Neumann, Franz-Josef; P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 100 KB

TCT-224: Use of a Low-Dose (LD) Paclitax

TCT-224: Use of a Low-Dose (LD) Paclitaxel Formulation on the Novel, Biodegradable, Minimal Polymer JACTAX Stent: Primary Endpoint Results from the JACTAX LD Drug-Eluting Stent Trial

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A randomized multicenter comparison of h

A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study

✍ Koen Teeuwen, Tom Adriaenssens, Ben JL Van den Branden, José PS Henriques, Rene 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 315 KB

Vantage 1 Trial: A FIM Evaluation of the

Vantage 1 Trial: A FIM Evaluation of the Cinatra Corolimus-eluting Stent with a Bioabsorbable Omega-3 Fatty Acid Coating in De Novo Coronary Lesions

✍ J. Ormiston; M. Webster; F. De Vroey; S. El Jack; J. Stewart; P. Ruygrok 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

TCT-578 First-in-human Evaluation of a N

TCT-578 First-in-human Evaluation of a Novel Sirolimus-eluting Stent with a Bioabsorbable Polymer for the Treatment of Single, De Novo, Non-complex Coronary Lesions

✍ Erlon de Abreu-Silva; RICARDO COSTA; SAMEER DANI; Mirela Lima; HASIT JOSHI; JAY 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB